NEW Products.
- Published in:
- 2008
- Publication type:
- Product Review
Works matching DE "SANOFI-Aventis US LLC"
Results: 17
1
2
Seven days: 25?31 March 2011.
- Published in:
- Nature, 2011, v. 471, n. 7340, p. 552, doi. 10.1038/471552a
- Publication type:
- Article
3
Genzyme deal set to alter biotech landscape.
- Published in:
- Nature, 2011, v. 470, n. 7335, p. 449, doi. 10.1038/470449a
- By:
- Publication type:
- Article
4
Seven days: 18-24 February 2011.
- Published in:
- Nature, 2011, v. 470, n. 7335, p. 440, doi. 10.1038/470440a
- Publication type:
- Article
5
New Products.
- Published in:
- 2007
- Publication type:
- Product Review
6
Sanofi-Aventis et al. v. Apotex Inc. et al.: The one hundred eight million dollar question.
- Published in:
- Journal of Generic Medicines, 2012, v. 9, n. 2, p. 100, doi. 10.1177/1741134312445867
- By:
- Publication type:
- Article
7
Charles Hugh-Jones.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 12, p. 900, doi. 10.1038/nrd4190
- Publication type:
- Article
8
News in brief.
- Published in:
- Nature Reviews Drug Discovery, 2011, v. 10, n. 3, p. 165, doi. 10.1038/nrd3409
- Publication type:
- Article
9
Marc Cluzel.
- Published in:
- 2010
- By:
- Publication type:
- Interview
10
Trial watch: novel antiarrhythmic agent shows promise in Phase III trial.
- Published in:
- 2009
- Publication type:
- journal article
11
Dronedarone: A New Therapeutic Alternative for Cardiac Arrhythmias.
- Published in:
- Journal of Young Pharmacists, 2010, v. 2, n. 4, p. 430, doi. 10.4103/0975-1483.71620
- By:
- Publication type:
- Article
12
US Judge rules Lilly's Zyprexa patent valid.
- Published in:
- Journal of Intellectual Property Rights, 2005, v. 10, n. 3, p. 255
- Publication type:
- Article
13
The quest for better diabetes control.
- Published in:
- 2015
- By:
- Publication type:
- Product Review
14
New Anti-Arrhythmic Drug Now Available.
- Published in:
- 2009
- Publication type:
- Product Review
15
Efficacy and safety of MYL‐1501D versus insulin glargine in people with type 1 diabetes mellitus: Results of the INSTRIDE 3 phase 3 switch study.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 3, p. 365, doi. 10.1111/dom.13904
- By:
- Publication type:
- Article
16
Revised Prescribing Information for Oxaliplatin Includes 6-Year Survival Data.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 7, p. 770
- Publication type:
- Article
17
U.S. R&D Spending To Grow in 2008.
- Published in:
- Research Technology Management, 2007, v. 50, n. 5, p. 8
- Publication type:
- Article